T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Enova International
ENVA
$6.48B
| $581K | ﹤0.01% |
20,176
-261
| -1% | -$8.63K |
|
|
ECHO
2152
EchoStar
ECHO
$26.6B
| $579K | ﹤0.01% |
29,998
+10,627
| +55% | +$240K |
|
|
TBCH
2153
Turtle Beach Corp
TBCH
$230M
| $577K | ﹤0.01% |
47,140
+2,800
| +6% | +$47.7K |
|
2154
American Vanguard Corp
AVD
$64M
| $574K | ﹤0.01% |
25,682
-1,443,104
| -98% | -$32.3M |
|
2155
Franklin Covey
FC
$234M
| $573K | ﹤0.01% |
12,411
-5,918
| -32% | -$235K |
|
2156
Koppers
KOP
$857M
| $572K | ﹤0.01% |
25,267
+1,822
| +8% | +$46.2K |
|
|
VXRT
2157
DELISTED
Vaxart
VXRT
| $572K | ﹤0.01% |
163,418
+84,700
| +108% | +$316K |
|
|
RWT
2158
Redwood Trust
RWT
$592M
| $571K | ﹤0.01% |
74,092
+954
| +1% | +$8.77K |
|
2159
Tejon Ranch
TRC
$441M
| $571K | ﹤0.01% |
36,809
+200
| +0.5% | +$3.45K |
|
2160
Worthington Enterprises
WOR
$2.78B
| $568K | ﹤0.01% |
20,904
+1,985
| +10% | +$57.5K |
|
2161
M/I Homes
MHO
$3.82B
| $567K | ﹤0.01% |
14,292
+86
| +0.6% | +$3.74K |
|
|
NSTG
2162
DELISTED
NanoString Technologies, Inc.
NSTG
| $566K | ﹤0.01% |
44,545
-326,511
| -88% | -$6.08M |
|
2163
Quanex
NX
$1B
| $564K | ﹤0.01% |
24,808
+284
| +1% | +$5.93K |
|
|
CYBR
2164
DELISTED
CyberArk
CYBR
| $563K | ﹤0.01% |
4,402
+101
| +2% | +$14.6K |
|
|
WIRE
2165
DELISTED
Encore Wire Corp
WIRE
| $563K | ﹤0.01% |
5,416
+49
| +0.9% | +$5.79K |
|
2166
Axsome Therapeutics
AXSM
$11.2B
| $560K | ﹤0.01% |
14,627
+245
| +2% | +$7.75K |
|
2167
Deluxe
DLX
$1.09B
| $558K | ﹤0.01% |
25,768
+2,296
| +10% | +$58.5K |
|
2168
Forward Air
FWRD
$658M
| $558K | ﹤0.01% |
6,069
+1,227
| +25% | +$114K |
|
2169
Green Plains
GPRE
$1.06B
| $558K | ﹤0.01% |
20,532
+444
| +2% | +$13.9K |
|
|
OPI
2170
DELISTED
Office Properties Income Trust
OPI
| $558K | ﹤0.01% |
27,978
+268
| +1% | +$5.8K |
|
2171
Materion
MTRN
$5.9B
| $557K | ﹤0.01% |
7,555
-845
| -10% | -$67.9K |
|
2172
West Bancorporation
WTBA
$511M
| $556K | ﹤0.01% |
22,825
+100
| +0.4% | +$2.49K |
|
2173
First Financial Corp
THFF
$970M
| $555K | ﹤0.01% |
12,467
-1,059
| -8% | -$46.4K |
|
|
DMC
2174
Del Monte Corp
DMC
$1.42B
| $553K | ﹤0.01% |
18,711
-26
| -0.1% | -$663 |
|
|
KE
2175
Kimball Electronics
KE
$606M
| $552K | ﹤0.01% |
27,450
+1,200
| +5% | +$22.6K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.